POS0637 COST-EFFECTIVENESS ANALYSIS OF UPADACITINIB VERSUS ALTERNATIVE TREATMENT STRATEGIES FOR RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO TNFi IN THE UNITED KINGDOM
POS0637 COST-EFFECTIVENESS ANALYSIS OF UPADACITINIB VERSUS ALTERNATIVE TREATMENT STRATEGIES FOR RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO TNFi IN THE UNITED KINGDOM